Head-to-head comparisons of medication uses, side effects, warnings, and more.
Libtayo (cemiplimab or cemiplimab-rwlc) is an immunotherapy medication that’s used to treat certain types of skin cancer and non-small cell lung cancer (NSCLC). It turns on your immune system to attack and kill cancer cells. But as a result, it can sometimes cause side effects like rash, diarrhea, and lung problems, which might require special treatment with corticosteroids. Libtayo (cemiplimab) is given through the vein (intravenously, IV) at a provider’s office or infusion center once every three weeks.
Keytruda (pembrolizumab) is an immunotherapy medication that’s used to treat many different types of cancer, including non-small cell lung cancer (NSCLC), breast cancer, and melanoma. This medication turns on your immune system so it can attack cancer cells. It's given as an intravenous (IV) infusion at a medical office or infusion center. Sometimes, Keytruda (pembrolizumab) can cause side effects, like diarrhea, rash, and trouble breathing, that might need to be treated with corticosteroids. Depending on the cancer, your treatment plan can consist of Keytruda (pembrolizumab) by itself or with other anticancer therapy.
Certain skin cancers
Certain non-small cell lung cancers that have spread
Certain types of:
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.